HLA-DR Antibodies

Santa Cruz Biotechnology offers a broad range of HLA-DR monoclonal antibodies for research in immunology and cell biology. HLA-DR monoclonal antibodies perform effectively in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-DR is a critical component of the major histocompatibility complex (MHC) class II molecules, playing a vital role in the immune response by presenting peptides to CD4+ T cells. This function is essential for the activation of the adaptive immune system, influencing both humoral and cellular immunity. Understanding HLA-DR's role is crucial for research into autoimmune diseases, transplant rejection, and vaccine development. HLA-DR monoclonal antibodies enable precise detection and analysis of MHC class II expression patterns across different cell types. Researchers can utilize HLA-DR monoclonal antibodies to investigate antigen presentation mechanisms and immune cell interactions. Additionally, HLA-DR monoclonal antibodies support studies focused on understanding immune system regulation and development. Santa Cruz Biotechnology monoclonal antibodies for HLA-DR research continue to advance our understanding of immune system function and disease mechanisms.